Search results for "Haloperidol"

showing 10 items of 50 documents

Sex differences in escape-avoidance response in mice after acute administration of raclopride, clozapine, and SCH 23390.

1998

Sex differences in the effects of haloperidol in the escape-avoidance response in mice have previously been found in various studies carried out in our laboratory. Males were more affected than females by the disruptive effects of this neuroleptic. The work described herein extended the study of these sex differences to raclopride, clozapine, and SCH 23390, using several doses of each drug in acute administration. The results showed dose-dependent sex differences in the deteriorating effects of these dopamine antagonists in the escape-avoidance response. Male mice were more affected by the inhibitory effects of these drugs, showing fewer escape responses and more nonresponses than females. …

Malemedicine.medical_specialtyClinical BiochemistryEscape responsePharmacologyToxicologyBiochemistryBehavioral NeuroscienceMiceDopamineEscape ReactionInternal medicineSalicylamidesmedicineHaloperidolAvoidance LearningAnimalsClozapineBiological PsychiatryPharmacologyRacloprideSex CharacteristicsDose-Response Relationship DrugReceptors Dopamine D1DopaminergicDopamine antagonistBenzazepinesDopamine D2 Receptor AntagonistsEndocrinologyDopamine receptorRacloprideDopamine AntagonistsFemalePsychologymedicine.drugSex characteristicsPharmacology, biochemistry, and behavior
researchProduct

Sex differences in the effects of neuroleptics on escape-avoidance behavior in mice: a review.

1999

Abstract The literature of the effects of dopamine antagonists on escape-avoidance, focusing on data obtained in our laboratory with male and female mice, is reviewed. The acute administration of haloperidol, raclopride, clozapine, and SCH 23390 impaired escape-avoidance behavior more in males than in females, and the subchronic administration of haloperidol had a similar effect. This appeared to be a reliable phenomenon, because it was observed in both kinds of administration, in two mouse strains, and with several drugs and doses. The observed results were dose dependent, although the dose–effect relationship was not the same in all drugs. The sex differences in escape avoidance did not s…

Malemedicine.medical_specialtyClinical BiochemistryToxicologyBiochemistryBehavioral Neurosciencechemistry.chemical_compoundMiceDopamineEscape ReactionInternal medicinemedicineHaloperidolAvoidance LearningAnimalsBiological PsychiatryClozapinePharmacologyRacloprideSCH-23390Sex CharacteristicsDopamine antagonistAntagonistEndocrinologychemistryDopamine receptorRacloprideHaloperidolFemalePsychologymedicine.drugAntipsychotic AgentsPharmacology, biochemistry, and behavior
researchProduct

Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice.

2001

The effects of dopamine (DA) antagonists with different selectivity for the DA receptors (SCH 23390, 0.5, 0.25, 0.125 mg/kg; haloperidol, 0.2, 0.1 mg/kg; raclopride, 1.2, 0.6, 0.3 mg/kg; risperidone, 0.4, 0.2, 0.1 mg/kg; U-99194A maleate, 40, 20 mg/kg; clozapine, 2.5, 1.25, 0.625 mg/kg) on the acquisition of place conditioning and morphine-induced conditioned place preference (CPP) were explored in male mice. Morphine (40 mg/kg) produced CPP while SCH 23390, haloperidol and clozapine (highest dose) and risperidone (lowest dose) produced conditioned place aversion (CPA). Raclopride and U-99194A maleate did not produce CPP or CPA. Morphine-induced CPP was reversed by the administration of SCH…

Malemedicine.medical_specialtyConditioning ClassicalPharmacologyChoice BehaviorReceptors DopamineBehavioral Neurosciencechemistry.chemical_compoundMiceDopamineInternal medicineOrientationpolycyclic compoundsmedicineHaloperidolAvoidance LearningAnimalsRacloprideSCH-23390MotivationDose-Response Relationship DrugMorphineChemistryAntagonistBrainConditioned place preferenceEndocrinologyDopamine receptorMorphineDopamine Antagonistsmedicine.drugBehavioural brain research
researchProduct

Sensitization to the rewarding effects of morphine depends on dopamine

2005

The influence of dopamine (DA) on sensitization to the rewarding effects of morphine was evaluated. The effects of pre-treatment with saline or morphine plus naloxone, CGS 10746B, haloperidol, SCH 23390 and raclopride, on the place conditioning induced by 2 mg/kg morphine were evaluated. This dose was ineffective in saline pre-treated animals but induced a clear conditioned place preference in mice pre-treated with morphine, CGS 10746B or haloperidol. Conversely, animals pre-treated with morphine plus naloxone, CGS 10746B, SCH 23390, raclopride and the high dose of haloperidol did not acquire place preference. Our results demonstrated that DA release and subsequent DA D1 and D2 receptor act…

Malemedicine.medical_specialtyDopamine(+)-NaloxonePharmacologyReceptors DopamineMicechemistry.chemical_compoundRewardInternal medicineDopamine receptor D2Conditioning PsychologicalHaloperidolmedicineAnimalsSensitizationRacloprideSCH-23390MorphineNaloxoneGeneral NeuroscienceBenzazepinesConditioned place preferenceEndocrinologymedicine.anatomical_structurechemistryMorphinemedicine.drugNeuroReport
researchProduct

Carnitine congener mildronate protects against stress- and haloperidol-induced impairment in memory and brain protein expression in rats.

2014

The present study investigates the efficacy of mildronate, a carnitine congener, to protect stress and haloperidol-induced impairment of memory in rats and the expression of brain protein biomarkers involved in synaptic plasticity, such as brain-derived neurotrophic factor (BDNF), acetylcholine esterase and glutamate decarboxylase 67 (GAD67). Two amnesia models were used: 2h immobilization stress and 3-week haloperidol treatment. Stress caused memory impairment in the passive avoidance test and induced a significant 2-fold BDNF elevation in hippocampal and striatal tissues that was completely inhibited by mildronate. Mildronate decreased the level of GAD67 (but not acetylcholine esterase) e…

Malemedicine.medical_specialtyGlutamate decarboxylaseAmnesiaNerve Tissue ProteinsHippocampal formationGPI-Linked ProteinsNeurotrophic factorsMemoryStress PhysiologicalInternal medicineCarnitinemedicineHaloperidolAvoidance LearningMemory impairmentAnimalsCarnitineRats WistarMaze LearningPharmacologyChemistryGlutamate DecarboxylaseBrain-Derived Neurotrophic FactorBrainRatsEndocrinologyNeuroprotective AgentsSynaptic plasticityAcetylcholinesteraseHaloperidolmedicine.symptomNeuroscienceBiomarkersmedicine.drugMethylhydrazinesEuropean journal of pharmacology
researchProduct

Dopamine acting through D2 receptors modulates the expression of PSA-NCAM, a molecule related to neuronal structural plasticity, in the medial prefro…

2008

A "neuroplastic" hypothesis proposes that changes in neuronal structural plasticity may underlie the aetiology of depression and the action of antidepressants. The medial prefrontal cortex (mPFC) is affected by this disorder and shows an intense expression of the polysialylated form of the neural cell adhesion molecule (PSA-NCAM), a plasticity-associated molecule, which is expressed mainly in interneurons. The monoamines serotonin, dopamine and noradrenaline are the principal targets of antidepressant action. Pharmacological manipulation of serotonin levels regulates synaptophysin and PSA-NCAM expression in the adult mPFC. However, the involvement of structural plasticity on the antidepress…

Malemedicine.medical_specialtyInterneuronDopamineSynaptophysinPrefrontal CortexNeural Cell Adhesion Molecule L1Synaptic TransmissionDopamine agonistRats Sprague-DawleyDevelopmental NeuroscienceDopamineDopamine receptor D2Internal medicinePhenethylaminesmedicineAnimalsNeuronsAnalysis of VarianceMicroscopy ConfocalNeuronal PlasticityGlutamate DecarboxylaseReceptors Dopamine D2ChemistryDopaminergicDopamine antagonistImmunohistochemistryRatsmedicine.anatomical_structureEndocrinologynervous systemNeurologyDopamine receptorDopamine AgonistsSialic AcidsDopamine AntagonistsHaloperidolNeural cell adhesion moleculeNeurosciencemedicine.drugExperimental Neurology
researchProduct

Pharmacological analysis of the responsiveness of guinea-pig lung parenchymal strip to dopamine

1984

Abstract Responses to dopamine were examined in the guinea-pig isolated lung parenchymal strip. Complete cumulative concentration-response curves to dopamine exhibited a biphasic pattern with a small initial contraction at concentrations below 10(-5) M followed by a dose-dependent relaxation at higher concentrations. Phentolamine (10(-5) M) completely abolished the contractile component and enhanced sensitivity and maximal relaxation to dopamine. In the presence of phentolamine, propranolol antagonized the dopamine-induced relaxation (pA2 = 8.54 +/- 0.07). In the presence of propranolol (10(-6) M), dopamine produced a dose-related contraction displaced to the right by phentolamine. Incubati…

Malemedicine.medical_specialtyReserpineContraction (grammar)DopamineGuinea PigsPropranololIn Vitro TechniquesPharmacologyNorepinephrinePhentolamineCocaineDopamineInternal medicinemedicineHaloperidolAnimalsPhentolamineLungPharmacologyChemistryAirway ResistanceIsoproterenolReserpinePropranololAcetylcholineEndocrinologyCatecholamineAcetylcholineResearch Articlemedicine.drugBritish Journal of Pharmacology
researchProduct

Dose Dependency of Sex Differences in the Effects of Repeated Haloperidol Administration in Avoidance Conditioning in Mice

1999

Sex differences in the effects of haloperidol in active avoidance conditioning in mice have previously been found in various studies carried out in our laboratory. Males were more affected than females by the disruptive effects of this neuroleptic. The work described here broadens the study of these sex differences to higher doses of haloperidol (0.1 and 0.2 mg/kg) using a repeated administration schedule (5 days). The results did not show sex differences in the deteriorating effects of this dopamine antagonist in the escape-avoidance response, but a tendency in the number of nonresponses was observed in the same direction as former results: male animals were more sensitive than females to …

Malemedicine.medical_specialtyTime FactorsClinical BiochemistryDose dependenceToxicologyBiochemistryMiceBehavioral NeuroscienceInternal medicineAvoidance LearningmedicineHaloperidolAnimalsMemory disorderBiological PsychiatryPharmacologySex CharacteristicsDose-Response Relationship DrugAvoidance ConditioningDopamine antagonistAntagonistmedicine.diseaseEndocrinologyAnesthesiaToxicityHaloperidolFemalePsychologyAntipsychotic Agentsmedicine.drugSex characteristicsPharmacology Biochemistry and Behavior
researchProduct

Rotarod impairment: catalepsy-like screening test for antipsychotic side effects.

2009

Extrapyramidal motoric symptoms are casual side effects under antipsychotic medication. New generation antipsychotics are expected to have a reduced risk due to different receptor affinities. Here, haloperidol and the new generation antipsychotics, risperidone, amisulpride, and aripiprazole, were examined with both catalepsy test and rotarod performance test to screen for their usability in mice. Mice treated with haloperidol, risperidone, and aripiprazole showed dose and time-dependent impairment. Amisulpride-treated mice showed no signs of catalepsy. Catalepsy test and rotarod performance test were useful methods to detect side effects of both generation antipsychotics. Catalepsy test pro…

Malemedicine.medical_specialtyTime FactorsScreening testmedicine.medical_treatmentStatistics as TopicDrug Evaluation PreclinicalCatalepsyPharmacologyMotor ActivityRotarod performance testMiceBasal Ganglia DiseasesmedicineHaloperidolAnimalsAmisulprideAntipsychoticPsychiatryFreezing Reaction CatalepticRisperidoneDose-Response Relationship DrugGeneral NeuroscienceGeneral Medicinemedicine.diseaseDisease Models AnimalRotarod Performance TestAripiprazolePsychologymedicine.drugAntipsychotic AgentsThe International journal of neuroscience
researchProduct

Effects of clozapine metabolites and chronic clozapine treatment on rat brain GABAA receptors

1996

Abstract Similarly to clozapine, a clozapine metabolite, N -desmethylclozapine, but not clozapine N -oxide, antagonized brain γ-aminobutyric acid type A (GABA A ) receptors at high micromolar concentrations. However, daily subcutaneous injections of clozapine (10 and 25 mg/kg) and haloperidol (0.5 mg/kg) for 14 days failed to alter the modulation by GABA of rat cerebrocortical and cerebellar benzodiazepine ([ 3 H]flunitrazepam) or convulsant ( t -[ 35 S]bicyclophosphorothionate) binding sites of the GABA A receptor. The results thus suggest that the GABA A receptor antagonism exerted by chronic in vivo clozapine treatment is weak as compared to this treatment's actions on certain monoamine …

Malemedicine.medical_specialtyTime Factorsmedicine.drug_classDrug Evaluation PreclinicalDesmethylclozapineIn Vitro TechniquesPharmacologyBiologyGABA AntagonistsRats Sprague-Dawleychemistry.chemical_compoundInternal medicinemedicineHaloperidolAnimalsGABA-A Receptor AntagonistsReceptorClozapineClozapinePharmacologyBenzodiazepineGABAA receptorBrainRatsLogistic ModelsEndocrinologychemistryConvulsantHaloperidolFlunitrazepamAntipsychotic Agentsmedicine.drugEuropean Journal of Pharmacology
researchProduct